PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Adents Introduces First Online Demo Platform for Cloud-based Pharma Serialization Solution

Serialization solutions leader launches user-friendly demo tool to test-drive signature Cloud traceability solution, Adents Prodigi
 
Adents, a leading provider of premier, versatile serialization and track & trace solutions, is launching an online demonstration tool showcasing Adents Prodigi, a Cloud traceability solution that centrally manages pharmaceutical serialization regulatory requirements across a comprehensive set of production and supply chain scenarios. The new, free tool can be accessed by current and prospective Adents customers at www.adents-prodigi.com.
The demo tool amounts to a test drive of Adents’ signature enterprise level (Level 4) serialization solution. Visitors can experience various functionalities to discover ways in which Adents Prodigi may benefit their business. The first of its kind for such a sophisticated, Cloud-based serialization solution, the demo tool provides both insight and transparency, adding tangibility to the complex, multi-faceted track & trace arena.
The demo tool works in an easy-to-use “if/then” setup. Users can build and add manufacturing facilities, “work” with hypothetical trading partners, add or subtract regulations and target markets, and explore other situational factors that showcase Adents Prodigi’s ability to seamlessly handle a wide array of supply chain scenarios. The demo also allows users to see how Adents Prodigi ties unit levels to bundles and pallets per the industry standard parent-child relationship.
Adents Prodigi entered the market as the only Cloud traceability solution that can centrally manage regulatory requirements mandated in the pharmaceutical industry, connect multiple trading partners, and allow pharmaceutical companies and CMOs to benefit from the massive amounts of data generated during the serialization and track & trace process.
Further, Adents Prodigi opens up new horizons beyond regulatory compliance, in terms of data analysis (including Microsoft Power BI), machine learning tools, or additional capabilities through existing in-house or third-party solutions.
“By offering this unique way of testing Adents Prodigi, we want to prove to the Life Science Market that they can address the challenges of connecting multiple trading partners, managing dozens of countries regulations and take advantage of their serialization data with a very user-friendly platform,” said Christophe Devins, CEO of Adents. “Our 25 years of serialization experience and close partnership with Microsoft’s development team gave us the keys to develop this best-in-class, versatile solution.”
Via Adents Prodigi, Adents became the first European provider to offer a certified Gateway to the European Medicines Verification System (EMVS). Having joined the pilot program, Adents is in the process of connecting Prodigi with the Russian Hub, and integration with Origin – a central data repository in the United States operated by the Healthcare Distribution Alliance (HDA) – is underway.
Adents will showcase the new demo tool at Pharmapack Europe in Paris February 7-8,  in Booth G66, Hall 7.1.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026